Qiagen N.V. (QGEN) Income Statement
QGEN 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsQGEN revenue and net income
Where QGEN's revenue goes
2025Each bar shows an amount and its share of revenue. QGEN kept 20.3% of revenue as net income.
QGEN profit margins
QGEN growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +5.7% | −0.8% | +2.2% | +5.0% |
| Gross profit | +33.5% | −2.3% | +0.9% | +4.6% |
| Operating income | +432.5% | −0.7% | +6.1% | +11.2% |
| Net income | +408.3% | +0.1% | +3.4% | +12.6% |
| EPS (diluted) | +4.7% | −2.2% | +0.6% | +7.0% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
QGEN quarterly EPS vs estimates
Qiagen beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 3, 2026 (estimate $0.62).
QGEN income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.09B | $1.98B | $1.97B | $2.14B | $2.25B | $1.87B | $1.53B | $1.50B | $1.42B | $1.34B |
| Cost of revenue | $798.5M | $1.01B | $731.6M | $757.0M | $800.8M | $637.6M | $521.2M | $500.9M | $495.0M | $493.3M |
| Gross profit | $1.29B | $967.4M | $1.23B | $1.38B | $1.45B | $1.23B | $1.01B | $1.00B | $922.6M | $844.7M |
| Research & development | $187.5M | $193.5M | $198.5M | $189.9M | $190.0M | $149.1M | $157.4M | $161.9M | $154.1M | $176.1M |
| Sales, general & admin | $583.7M | $564.4M | $579.2M | $603.9M | $584.5M | $525.4M | $504.2M | $533.5M | $575.7M | $530.6M |
| Total operating expenses | $771.2M | $869.6M | $823.8M | $853.1M | $820.7M | $846.3M | $1.03B | $734.4M | $769.1M | $745.8M |
| Operating income | $520.3M | $97.7M | $409.9M | $531.5M | $630.1M | $386.4M | −$26.1M | $266.6M | $153.4M | $98.8M |
| Interest income | $64.3M | $68.0M | $76.0M | $32.8M | $9.6M | $10.0M | $22.1M | $20.9M | $10.6M | $6.8M |
| Interest expense | $33.3M | $43.8M | $53.4M | $58.4M | $54.5M | $71.3M | $74.2M | $67.3M | $49.7M | $39.0M |
| Income before taxes | $490.3M | $121.1M | $429.8M | $512.6M | $625.8M | $439.5M | −$77.8M | $225.7M | $114.4M | $56.9M |
| Income taxes | $65.4M | $37.6M | $88.5M | $89.4M | $113.2M | $80.3M | −$36.3M | $35.4M | $74.0M | −$23.4M |
| Net income | $424.9M | $83.6M | $341.3M | $423.2M | $512.6M | $359.2M | −$41.5M | $190.4M | $40.4M | $80.4M |
| EBITDA | $717.3M | $368.3M | $688.6M | $779.4M | $895.2M | $715.8M | $227.9M | $499.5M | $380.5M | $309.0M |
| EPS (diluted) | $2.47 | $2.36 | $2.30 | $2.64 | $2.97 | $2.40 | $1.61 | $1.50 | $1.39 | $1.28 |
| Gross margin | 61.8% | 48.9% | 62.8% | 64.7% | 64.4% | 65.9% | 65.9% | 66.6% | 65.1% | 63.1% |
| Operating margin | 24.9% | 4.9% | 20.9% | 24.8% | 28.0% | 20.7% | −1.7% | 17.8% | 10.8% | 7.4% |
| Net margin | 20.3% | 4.2% | 17.4% | 19.8% | 22.8% | 19.2% | −2.7% | 12.7% | 2.8% | 6.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $535.0M | $492.3M | $540.4M | $532.6M | $533.5M | $483.5M | $521.2M | $501.9M | $496.3M | $458.8M | $509.2M | $475.9M |
| Cost of revenue | $194.7M | $182.7M | $223.2M | $201.3M | $199.3M | $174.8M | $187.9M | $193.6M | $461.6M | $167.8M | $193.1M | $177.9M |
| Gross profit | $340.4M | $309.6M | $317.3M | $331.3M | $334.3M | $308.7M | $333.3M | $308.3M | $34.8M | $291.0M | $316.1M | $298.0M |
| Research & development | $50.4M | $48.3M | $47.2M | $48.7M | $47.8M | $43.8M | $48.6M | $44.5M | $49.1M | $51.3M | $46.0M | $47.9M |
| Sales, general & admin | $146.8M | $142.4M | $33.1M | $143.1M | $148.7M | $137.9M | $141.7M | $140.7M | $143.3M | $138.7M | $146.0M | $140.1M |
| Total operating expenses | $208.0M | $193.0M | $163.4M | $202.1M | $212.4M | $193.3M | $214.2M | $196.2M | $263.2M | $196.0M | $205.5M | $200.8M |
| Operating income | $132.4M | $116.6M | $153.9M | $129.2M | $121.9M | $115.3M | $119.1M | $112.1M | −$228.4M | $94.9M | $110.6M | $97.2M |
| Interest income | $9.4M | $10.6M | $20.0M | $15.1M | $13.9M | $15.4M | $15.1M | $18.3M | $16.9M | $17.8M | $19.3M | $20.4M |
| Interest expense | $10.0M | $11.1M | $10.1M | $8.2M | $7.6M | $7.3M | $11.1M | $11.5M | $10.9M | $10.3M | $12.4M | $13.0M |
| Income before taxes | $132.1M | $85.8M | $109.2M | $134.7M | $126.8M | $119.5M | $125.9M | $116.5M | −$223.5M | $102.3M | $118.9M | $99.8M |
| Income taxes | $28.7M | $17.8M | $1.3M | $4.7M | $30.6M | $28.8M | $37.5M | $18.4M | −$40.0M | $21.6M | $21.2M | $22.0M |
| Net income | $103.4M | $68.0M | $107.8M | $130.0M | $96.2M | $90.8M | $88.3M | $98.1M | −$183.5M | $80.7M | $97.7M | $77.8M |
| EBITDA | $192.7M | $148.1M | $168.7M | $193.9M | $183.9M | $170.8M | $182.5M | $177.9M | −$159.1M | $166.9M | $182.9M | $163.4M |
| EPS (diluted) | $0.62 | $0.54 | $0.62 | $0.64 | $0.63 | $0.58 | $0.64 | $0.62 | $0.60 | $0.50 | $0.60 | $0.56 |
| Gross margin | 63.6% | 62.9% | 58.7% | 62.2% | 62.7% | 63.8% | 63.9% | 61.4% | 7.0% | 63.4% | 62.1% | 62.6% |
| Operating margin | 24.7% | 23.7% | 28.5% | 24.3% | 22.8% | 23.9% | 22.9% | 22.3% | −46.0% | 20.7% | 21.7% | 20.4% |
| Net margin | 19.3% | 13.8% | 20.0% | 24.4% | 18.0% | 18.8% | 16.9% | 19.5% | −37.0% | 17.6% | 19.2% | 16.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in QGEN's financial statements (latest annual report filed March 20, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
QGEN financial results
In fiscal year 2025 (ended December 31, 2025), Qiagen reported revenue of $2.1 billion, up 5.7% from the year before. It had net income of $424.9 million (up 408.3%), a net profit margin of 20.3%. Diluted earnings per share came to $2.47. Over five years revenue grew at an average rate of 2.2% a year.
See the QGEN stock overview for the latest quote and news, or the QGEN chart for price history and technical indicators.
QGEN income statement FAQ
What is Qiagen's annual revenue?
Qiagen reported total revenue of $2.1 billion for fiscal year 2025, which ended on December 31, 2025. That was up 5.7% from $2.0 billion the previous year.
Is Qiagen profitable?
Yes. Qiagen reported net income of $424.9 million in fiscal 2025, a net profit margin of 20.3%; its operating margin was 24.9%.
What is Qiagen's gross margin?
Qiagen's gross margin was 61.8% in fiscal 2025: for every $100 of revenue, Qiagen kept $62 after the direct cost of its products and services.
How much does Qiagen spend on research and development?
Qiagen spent $187.5 million on research and development in fiscal 2025, 9.0% of revenue.
How fast is Qiagen growing?
Revenue grew 2.2% a year on average over the last five fiscal years, from $1.9 billion to $2.1 billion.
What are Qiagen's earnings per share?
Qiagen earned $2.47 per diluted share in fiscal 2025, compared with $2.36 a year earlier.
When will Qiagen report its next earnings?
Qiagen is expected to report results for the quarter ending September 30, 2026 on November 3, 2026.
When does Qiagen's fiscal year end?
Qiagen's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 20, 2026.